CTOs on the Move


 
uBiome is the leading microbial genomics company. We are pioneering a new era of microbiome-based precision medicine. We allow doctors, patients, and citizen scientists to learn about the human microbiome with unprecedented accuracy and speed.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

uBiome raised $26.62M on 11/02/2016
uBiome raised $83M on 09/21/2018

Similar Companies

Collective Medical

Collective Medical empowers care teams to improve patient outcomes by closing the communication gaps that undermine patient care through seamless collaboration. With a nationwide network engaged with every national health plan in the country, hundreds of hospitals and health systems and tens of thousands of providers—including hospitals, emergency departments, skilled nursing facilities, primary care providers, mental and behavioral health clinics, and others—Collective Medical`s system-agnostic platform is trusted by healthcare organizations and payers to identify at-risk and complex patients and facilitate actionable collaboration to make better care decisions and improve outcomes. Based in Salt Lake City, Collective Medical is proven to streamline transitions of care, improve coordination across diverse care teams, and reduce unnecessary hospital admissions.

LHM PTI

LHM Physical Therapy Institute is a full-service outpatient physical therapy provider in Pennsylvania that offers personalized care to enhance patients quality of life.

Evermore Cannabis

The Highest Standards For Creating Quality Medical Cannabis Products. Evermore manufactures and processes medical cannabis in the State of Maryland.

Binax

Binax, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Binax, Inc. is based in Scarborough, ME. You can find more information on Binax, Inc. at www.binax.com

Savient

Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing and commercializing KRYSTEXXA? (pegloticase) for the treatment of chronic gout in adult patients refractory to conventional therapy.